DocuSign Likely To Report Higher Q1 Revenue; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga
06 Jun

DocuSign, Inc. (NASDAQ:DOCU) will release its first-quarter earnings results after the closing bell on Thursday, June 5.

Analysts expect the San Francisco, California-based company to report quarterly earnings at 81 cents per share, down from 82 cents per share in the year-ago period. DocuSign projects to report quarterly revenue at $748.92 million, compared to $709.64 million a year earlier, according to data from Benzinga Pro.

On April 29, Docusign named Michael Adams as new Chief Information Security Officer.

DocuSign shares rose 2.4% to close at $93.84 on Wednesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • JMP Securities analyst Patrick Walravens reiterated a Market Outperform rating with a price target of $124 on June 3, 2025. This analyst has an accuracy rate of 63%.
  • UBS analyst Karl Keirstead maintained a Neutral rating and cut the price target from $90 to $85 on April 17, 2025. This analyst has an accuracy rate of 70%.
  • Morgan Stanley analyst Josh Baer maintained an Equal-Weight rating and cut the price target from $97 to $92 on April 16, 2025. This analyst has an accuracy rate of 63%.
  • Jefferies analyst Brent Thill maintained a Buy rating and slashed the price target from $115 to $105 on March 31, 2025. This analyst has an accuracy rate of 77%.
  • Citigroup analyst Tyler Radke maintained a Buy rating and raised the price target from $113 to $115 on March 14, 2025. This analyst has an accuracy rate of 71%.

Considering buying DOCU stock? Here’s what analysts think:

Read This Next:

  • Jim Cramer: Arrowhead Pharmaceuticals Doesn’t ‘Have The Horses’

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10